Interaction between hepatitis B and C viruses in hepatocellular carcinogenesis
Author:
- 24 January 2006
- journal article
- research article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 13 (3) , 145-149
Abstract
Summary. Although hepatitis B (HBV) and C viruses (HCV) are, individually, major causes of hepatocellular carcinoma, the interaction, if any, between the carcinogenic effects of the two viruses is uncertain. Equal numbers of published studies have reported no risk interaction or a synergistic risk interaction. These conflicting results are explained by the rarity of concurrent infection with HBV and HCV in individuals without clinically evident liver disease, which severely limits the ability to accurately estimate the hepatocarcinogenic risk of dual infection compared with that of either infection alone. In an attempt to circumvent this difficulty, two meta‐analyses have been performed, one based on studies published from a number of countries and the other on studies confined to Chinese patients. Both analyses concluded that a synergistic carcinogenic interaction existed between the two viruses and that the increased risk was super‐additive but not multiplicative. If confirmed, this risk interaction will occur against a background of negative confounding effects on viral replication between HBV and HCV, which may be reciprocal. The mechanisms responsible for the carcinogenic interaction between the viruses are unknown. One possibility is that the increased incidence of cirrhosis with concurrent HBV and HCV infections acts as an even more potent tumour promoter than occurs with either virus alone. Synergism between the direct hepatocarcinogenic effects of the two viruses is another possible mechanism, but proof will have to await a fuller understanding of the pathogenetic mechanisms involved with the individual viruses.Keywords
This publication has 47 references indexed in Scilit:
- Virological significance of low‐level hepatitis B virus infection in patients with hepatitis C virus associated liver diseaseJournal of Medical Virology, 2003
- Uses and abuses of meta-analysisClinical Medicine, 2001
- Survey of Hepatitis B Virus Co‐infection in Hepatitis C Virus‐infected Patients Suffering from Chronic Hepatitis and Hepatocellular Carcinoma in JapanJapanese Journal of Cancer Research, 1999
- The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacksGastroenterology, 1997
- Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitisJournal of Hepatology, 1996
- A case‐control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinomaInternational Journal of Cancer, 1995
- Coinfection of hepatitis C virus in patients with chronic hepatitis B infectionJournal of Hepatology, 1994
- Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinomaJournal of Hepatology, 1992
- Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinomaThe Lancet, 1990
- Integration of Hepatitis B Virus DNA into the Genome of Liver Cells in Chronic Liver Disease and Hepatocellular CarcinomaNew England Journal of Medicine, 1981